Dual Agonist
GLP-2 50 MG
A dual GIP/GLP-1 receptor agonist peptide studied in laboratory research on incretin signaling.
Choose a size
Research Use Only · No Medical Advice
Products are for in-vitro laboratory research only and are not for human or animal consumption. Information on this site is educational, is not medical advice, and has not been evaluated by the FDA.
Certificate of Analysis
- Purity (HPLC)
- 99.2%
- Lot number
- PL-TIRZ50-2410
- Tested
- 2026-10-06
- Formula
- C225H348N48O68
Full lot reports are available on request — send the lot number printed on your vial and we email you the report.
Research focus areas
- Dual GIP / GLP-1 receptor agonism research
- Incretin signaling pathway studies
- Metabolic and glucose-metabolism research models
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic.
What researchers are studying
Tirzepatide research explores dual GIP/GLP-1 receptor agonism and its effects on incretin signaling and metabolic pathways.
Browse published studies on PubMedFor research use only. Not for human or animal consumption. Not a drug, food, or cosmetic.